Can Toll-Like Receptor (TLR) 2 be considered as a new target for immunotherapy against hepatitis B infection?

✍ Scribed by Bagheri, Vahid; Askari, Azam; Arababadi, Mohammad Kazemi; Kennedy, Derek

• Book ID: 121798837
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 892 KB
• Volume: 75
• Category: Article
• ISSN: 0198-8859
• DOI: 10.1016/j.humimm.2014.02.018